Delivery Order HHSN261201600005I-75N91018F00005

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland. The contract is for Tissue Source Site (TSS) services in support of NCI's Clinical Proteomic Tumor Analysis Consortium, specifically for the analysis of 100 cases across Payments 1-3 at a rate of $2,000 per case (with an 85% payment factor). The total ceiling value of the contract is $402,700. This delivery order is part of...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Biopartners, Inc. for the TSS CPTAC DIGITAL MEDICAL IMAGES OF CPTAC BIOSPECIMENS project. The contract has a ceiling value of $12,240.00 and an ultimate completion date of September 17, 2018. It is part of the Tissue Source Site for Tumor Analysis master IDIQ contract. The contract does not have a set-aside designation. The award supports the NCI's Medical Images for CPTAC Biospecimens program.

This is a $2,502,392.00 definitive contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), to Case Western Reserve University to establish a Tissue Source Site (TSS) Network in support of the Cancer Genome Atlas (TCGA) program. The contract has a period of performance through September 30, 2014 and does not have a set-aside designation. The purpose of the contract is to provide clinically annotated biospecimens to the TCGA's...

This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Biomatrix LLC, a woman-owned and Asian-Pacific American-owned limited liability company, for $348,699.80. The award is for Biomatrix to serve as a Tissue Source Site (TSS) for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract has a period of performance through April 29, 2019 and does not have a set-aside designation. The CPTAC program is focused on the...

This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Biomatrix LLC, a woman-owned, Asian-Pacific American-owned limited liability company, for providing a Tissue Source Site (TSS) in support of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract is a Delivery Order with a Firm Fixed Price valued at $231,228.50. It does not have a set-aside designation and...

<p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to The International Genomics Consortium. The contract, with a ceiling value of $21,332,413.15, supports the Cancer Genome Atlas (TCGA) program through the establishment of Tissue Source Site (TSS) networks. The contract does not have a set-aside designation and was awarded on September 27, 2010, with a period of performance through September 30, 2014. The contract is a cost-no-fee contract type.</p>

This is a $37,262,683.59 definitive cost-no-fee contract awarded by the National Cancer Institute (NCI) to The International Genomics Consortium. The contract is for providing biospecimen processing services to support the Cancer Genome Atlas (TCGA) program, which is part of the National Institutes of Health's efforts to comprehensively characterize various cancer types. The contract has an ultimate completion date of December 30, 2012 and was awarded on September 24, 2010 as part of the...

This is a Firm Fixed Price Delivery Order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Indivumed, Inc., a For Profit Organization. The contract is for the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The potential value of this contract is $38,000.00. It is not associated with a set-aside designation. The contract is issued under the NCI Cancer Genome...

This federal contract award is for a Tissue Source Site (TSS) to support the National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The prime contractor, William Beaumont Hospital, doing business as Beaumont Health, is a non-profit hospital that will provide tissue samples for the CPTAC cancer research initiative. The contract has a ceiling value of $3,844.62 and an ultimate completion date of July 14, 2021. It is a firm fixed price delivery order under a...

This is a $142,143.34 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the University of Pittsburgh for the NCI's Cancer Genome Atlas (TCGA) program. The contract is to provide tissue samples and data from various types of cancer to support the TCGA program, which aims to construct a comprehensive &quot;atlas&quot; of the molecular changes involved in human cancers. The award is not set aside and is part of a larger IDIQ contract titled the &quot;NCI Cancer...